Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Chinese Pharma under Cloud Again in the Supposedly Lucky Year of the Pig Chief Editor James Shen offers his Annual Review of the Chinese Pharmaceutical Sector 2018 and Outlook for 2019, which provides an comprehensive overview of all important... (2/12/2019) Highlights of the Draft 4th Amendment to the Chinese Patent Law (2/14/2019) China's Biotechnology Development: The Role of U.S. and Other Foreign Engagement (2/14/2019) Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2018 (2/13/2019) Chinese Pharma under Cloud Again in the Supposedly Lucky Year of the Pig (2/12/2019) SAMR Fines Hunan Er-Kang And Henan Jiushi CNY 10M for Unfair Pricing Of Chlorpheniramine API (2/8/2019) How a Tainted Heart Drug Made in China Slipped Past the FDA (1/30/2019) Implications on the Draft Amendment to the Drug Administration Law and the Draft Heathcare Law in the Pharmaceutical industry in China (1/29/2019) Ropes & Gary: China Aims To Introduce Routine Drug And Device Overseas Inspections (1/22/2019) China Pharma Must Swallow That Jagged Little Pill Called R&D as Government Slashes Profit Margins of Generic Drugs (1/21/2019) China's Patent Flood Stifles Foreign Filer Freedom (1/17/2019) China's Biopharmas Buffeted by Clashing Market Dynamics (1/16/2019) The Chinese Stomach Cancer Market (1/10/2019) New Developments in the Fourth Amendment of the Patent Law of the PRC (1/10/2019) How Health Care Data and Lax Rules Help China Prosper in AI (1/8/2019) NYT: U.S. Officials Warn Health Researchers over China (1/8/2019) Recent Official and Executive Moves  (2/15/2019) NMPA Bans Compound Formulations Containi...  (2/15/2019) NHC Announces Plan for Nationwide Ad Hoc...  (2/14/2019) CStone Kicks Off First Biotech IPO of 20...  (2/14/2019) Burning Rock Completes Series C financin...  (2/14/2019) (free) Sinohealth: Chinese Retail Pharmacy Sale...  (2/14/2019) CDE Seeks Comments on Four Draft Chinese...  (2/13/2019) Ascletis and 3-V Biosciences Announce NA...  (2/13/2019) CDE Publicizes Information on 62 Newly A...  (2/12/2019) CDE Publicizes Two More Drug Application...  (2/12/2019) 3SBio and Verseau Establish Global Clini...  (2/12/2019) EdiGene Secures $15M in a Series Pre-B F...  (2/12/2019) (free) China Boosts Support of Anticancer and O...  (2/11/2019) USTR's 2018 Report for China's WTO Compl...  (2/9/2019) SAMR Unveils Its Legislation Plan in 201...  (2/3/2019) IQVIA: Global Pharma to Grow Slower in the Next Five Yea... Pfizer and GSK Announce JV to Create a Global Consumer H... Top 25 Global Pharmaceutical Companies by Market Cap 201... CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... Sinohealth: Chinese Retail Pharmacy Sales Slowed to the Lowest ... Nicholas Hall Reports 6% Growth for Chinese OTC VMS Market in 2... Chinese mAb Market to Grow 13.7% CAGR between 2017 and 2022 SMEI Predicts Four China Healthcare Sector Trends in 2019 IQVIA: Chinese Retail Pharmacy Market Growth Slowed in MAT Q3/2... CStone Kicks Off First Biotech IPO of 2019 on HKEx Burning Rock Completes Series C financing of CNY 850M Ascletis and 3-V Biosciences Announce NASH Strategic License... 3SBio and Verseau Establish Global Clinical Development Deal... EdiGene Secures $15M in a Series Pre-B Financing Round NMPA Bans Compound Formulations Containing Furazolidone CDE Seeks Comments on Four Draft Chinese Editions of ICH... CDE Publicizes Information on 62 Newly Approved GQCE App... CDE Publicizes Two More Drug Applications To Be Granted ... SAMR Unveils Its Legislation Plan in 2019 USTR's 2018 Report for China's WTO Compliance Highlight IP I... Report: China Tightens IP Protection and Expands Patent Refo... China Claims Steady Progress in Key Indicators of IP in 2018... China: Gene-Editing Scientist Broke Laws for ‘Personal Fame... Hogan Lovells: Pharma Companies May Benefit from Proposed Pa... Huahai Pharma Involved In Another Blood Pressure Drug Re... Novo Nordisk Pharmatech A/S signs Asia Pacific distribut... Trade Bodies Warns API Supply Chain Disruptions from Chi... India Seeks to Reduce Reliance on Chinese Pharma Imports... USFDA Warns Zhejiang Huahai for Failure to Detect Valsar... Hua Medicine Initiates First Combination Study of Dorzag... Innovent Files Chinese NDA for Its Biosimilar of Avastin... Lee's Pharma Completes Phase I Study of CVD Drug Tecarfa... China Joins the Race to Develop ASF Vaccine MabPlex's Manufactured mAb Receives IND Approval from th... NHC Announces Plan for Nationwide Ad Hoc Regulatory Samp... National Healthcare Security Administration Launches Off... Shanghai Streamlines Procurement and Consumption of Self... State Council Strengthens Performance Evaluation of Leve... NHC Issues Notice on Clinical Requirements for Prevailin... Recent Official and Executive Moves Recent Executive Moves Recent Executive Movements Recent Executive Moves Recent Executive Moves Call for Speakers - Upcoming Pharma China Annual Forum 2... Upcoming Event: Pediatrics Congress 2019 Upcoming Event: 12th international conference on Vascula... Upcoming Event: PHARM Connect Congress 2019 China to Launch New Tech Bourse in Shanghai Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON to Hold Pharma China Ann...   WiCON Publishes the China Phar...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links